MwanzoRLF • SWX
add
RELIEF THERAPEUTICS Holding SA
Bei iliyotangulia
CHF 2.88
Bei za siku
CHF 2.79 - CHF 2.88
Bei za mwaka
CHF 1.65 - CHF 7.60
Thamani ya kampuni katika soko
40.56M CHF
Wastani wa hisa zilizouzwa
elfu 20.74
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
SWX
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (CHF) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 609.00 | -78.18% |
Matumizi ya uendeshaji wa biashara | 2.57M | -35.75% |
Mapato halisi | -2.24M | 1.73% |
Kiwango cha faida halisi | -367.65 | -350.28% |
Mapato kwa kila hisa | — | — |
EBITDA | -2.01M | -42.73% |
Asilimia ya kodi ya mapato | 0.58% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (CHF) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 12.50M | — |
Jumla ya mali | 47.99M | — |
Jumla ya dhima | 15.35M | — |
Jumla ya hisa | 32.63M | — |
hisa zilizosalia | 12.58M | — |
Uwiano wa bei na thamani | 1.11 | — |
Faida inayotokana na mali | -11.77% | — |
Faida inayotokana mtaji | -16.36% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (CHF) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -2.24M | 1.73% |
Pesa kutokana na shughuli | -1.88M | -18.76% |
Pesa kutokana na uwekezaji | elfu 644.00 | 18,500.00% |
Pesa kutokana na ufadhili | elfu -28.50 | 90.75% |
Mabadiliko halisi ya pesa taslimu | -1.29M | 32.60% |
Mtiririko huru wa pesa | elfu -284.81 | — |
Kuhusu
Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung. The company was incorporated as Relief Therapeutics Holdings AG and listed on the SIX Swiss Exchange in 2016. Wikipedia
Ilianzishwa
2013
Tovuti
Wafanyakazi
28
